Teleflex [TFX] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
Teleflex
NYSE
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Teleflex wins in 7 metrics, Intuitive Surgical wins in 12 metrics, with 0 ties. Intuitive Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Teleflex | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.05 | 66.23 | Teleflex |
| Price-to-Book Ratio | 1.30 | 9.56 | Teleflex |
| Debt-to-Equity Ratio | 49.49 | 0.00 | Intuitive Surgical |
| PEG Ratio | 8.16 | 2.72 | Intuitive Surgical |
| EV/EBITDA | 8.03 | 51.94 | Teleflex |
| Profit Margin (TTM) | 6.31% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | 24.16% | 30.47% | Intuitive Surgical |
| EBITDA Margin (TTM) | 24.16% | 30.47% | Intuitive Surgical |
| Return on Equity | 4.36% | 16.04% | Intuitive Surgical |
| Return on Assets (TTM) | 5.41% | 9.02% | Intuitive Surgical |
| Free Cash Flow (TTM) | $509.31M | $1.30B | Intuitive Surgical |
| Dividend Yield | 0.87% | N/A | N/A |
| 1-Year Return | -46.61% | -2.14% | Intuitive Surgical |
| Price-to-Sales Ratio (TTM) | 1.81 | 18.67 | Teleflex |
| Enterprise Value | $7.34B | $165.47B | Intuitive Surgical |
| EV/Revenue Ratio | 2.42 | 18.09 | Teleflex |
| Gross Profit Margin (TTM) | 55.20% | 66.31% | Intuitive Surgical |
| Revenue per Share (TTM) | $66 | $26 | Teleflex |
| Earnings per Share (Diluted) | $4.29 | $7.19 | Intuitive Surgical |
| Beta (Stock Volatility) | 1.08 | 1.60 | Teleflex |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Teleflex vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Teleflex | -1.44% | 7.24% | 12.34% | 7.01% | -27.14% | -27.72% |
| Intuitive Surgical | -1.62% | -0.85% | -6.82% | -12.26% | -19.43% | -9.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Teleflex | -46.61% | -42.26% | -66.39% | -2.32% | 158.68% | 91.25% |
| Intuitive Surgical | -2.14% | 125.57% | 96.48% | 733.32% | 1,469.41% | 5,785.78% |
Performance & Financial Health Analysis: Teleflex vs Intuitive Surgical
| Metric | TFX | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $5.51B | $170.69B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 587,090 | 1,744,340 |
| 90 Day Avg. Volume | 584,093 | 2,077,840 |
| Last Close | $127.55 | $468.44 |
| 52 Week Range | $108.90 - $249.91 | $425.00 - $616.00 |
| % from 52W High | -48.96% | -23.95% |
| All-Time High | $449.38 (Apr 26, 2021) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -71.62% | -23.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.21% |
| Quarterly Earnings Growth | 0.53% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.29% |
| Operating Margin (TTM) | 0.24% | 0.30% |
| Return on Equity (TTM) | 0.04% | 0.16% |
| Debt to Equity (MRQ) | 49.49 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $96.01 | $49.79 |
| Cash per Share (MRQ) | $5.92 | $14.86 |
| Operating Cash Flow (TTM) | $514.28M | $2.83B |
| Levered Free Cash Flow (TTM) | $360.29M | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.87% | N/A |
| Last 12-Month Dividend | $1.02 | N/A |
Valuation & Enterprise Metrics Analysis: Teleflex vs Intuitive Surgical
| Metric | TFX | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.05 | 66.23 |
| Forward P/E | 8.16 | 60.58 |
| PEG Ratio | 8.16 | 2.72 |
| Price to Sales (TTM) | 1.81 | 18.67 |
| Price to Book (MRQ) | 1.30 | 9.56 |
| Market Capitalization | ||
| Market Capitalization | $5.51B | $170.69B |
| Enterprise Value | $7.34B | $165.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.42 | 18.09 |
| Enterprise to EBITDA | 8.03 | 51.94 |
| Risk & Other Metrics | ||
| Beta | 1.08 | 1.60 |
| Book Value per Share (MRQ) | $96.01 | $49.79 |
Financial Statements Comparison: Teleflex vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TFX | ISRG |
|---|---|---|
| Revenue/Sales | $780.89M | $2.44B |
| Cost of Goods Sold | $349.80M | $822.10M |
| Gross Profit | $431.09M | $1.62B |
| Research & Development | $38.52M | $313.30M |
| Operating Income (EBIT) | $177.48M | $743.40M |
| EBITDA | $244.84M | $898.70M |
| Pre-Tax Income | $135.25M | $832.10M |
| Income Tax | $12.66M | $167.90M |
| Net Income (Profit) | $122.58M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TFX | ISRG |
|---|---|---|
| Cash & Equivalents | $284.12M | $2.57B |
| Total Current Assets | $1.54B | $7.66B |
| Total Current Liabilities | $675.91M | $1.54B |
| Long-Term Debt | $1.90B | N/A |
| Total Shareholders Equity | $4.10B | $17.21B |
| Retained Earnings | $4.20B | $7.14B |
| Property, Plant & Equipment | $627.26M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TFX | ISRG |
|---|---|---|
| Operating Cash Flow | $109.80M | $833.10M |
| Capital Expenditures | N/A | $-116.60M |
| Free Cash Flow | $43.08M | $465.00M |
| Debt Repayment | $-49.13M | N/A |
| Common Stock Repurchase | $-300.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TFX | ISRG |
|---|---|---|
| Shares Short | 882,529 | 4.30M |
| Short Ratio | 1.52 | 2.18 |
| Short % of Float | 0.03% | 0.01% |
| Average Daily Volume (10 Day) | 587,090 | 1,744,340 |
| Average Daily Volume (90 Day) | 584,093 | 2,077,840 |
| Shares Outstanding | 46.27M | 356.60M |
| Float Shares | 44.03M | 356.31M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 1.02% | 0.89% |
Dividend Analysis & Yield Comparison: Teleflex vs Intuitive Surgical
| Metric | TFX | ISRG |
|---|---|---|
| Last 12-Month Dividend | $1.02 | N/A |
| Last 12-Month Dividend Yield | 0.87% | N/A |
| 3-Year Avg Annual Dividend | $1.13 | N/A |
| 3-Year Avg Dividend Yield | 0.16% | N/A |
| 3-Year Total Dividends | $3.40 | N/A |
| Ex-Dividend Date | Mar 07, 2025 | N/A |